REQUEST A DEMO
Total
USD $0.00
Search more companies

Insu & Med S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Retail Trade
Full name: Insu & Med S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Insu & Med S.A. is an enterprise located in Ecuador, with the main office in Guayaquil. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on January 31, 2020. There are currently 1 (2023) people employed by Insu & Med S.A.. The company’s latest financial report indicates a net sales revenue increase of 82.19% in 2022. Its total assets decreased by 35.29% over the same period. The net profit margin of Insu & Med S.A. decreased by 0.04% in 2022.

Headquarters
Sucre 222, San Lorenzo Piso 4 Ofic- 48 Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Insu & Med S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Insu & Med S.A. report to view the information.
Outstanding Shares:
Purchase the Insu & Med S.A. report to view the information.
Registered Capital:
Purchase the Insu & Med S.A. report to view the information.
Incorporation Date:
January 31, 2020
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Insu & Med S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
82.19%
Total operating revenue
82.19%
EBITDA
-83.37%
Net Profit (Loss) for the Period
37.48%
Total assets
-35.29%
Total equity
1.96%
Operating Profit Margin (ROS)
-0.39%
Net Profit Margin
-0.04%
Return on Equity (ROE)
0.5%
Quick Ratio
0.42%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?